|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03394846|
Recruitment Status : Recruiting
First Posted : January 9, 2018
Last Update Posted : April 17, 2019
|Condition or disease||Intervention/treatment||Phase|
|Physical Activity||Behavioral: Prototype Movement Integration Product||Phase 1|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||60 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Testing Products to Increase Children's Physical Activity in the Classroom: Identifying What Works and What Doesn't|
|Actual Study Start Date :||October 1, 2018|
|Estimated Primary Completion Date :||May 1, 2020|
|Estimated Study Completion Date :||May 1, 2020|
Experimental: Pilot Test of MI Prototype
We will pilot test a Movement Integration product prototype with 60 elementary classroom teachers.
Behavioral: Prototype Movement Integration Product
A movement integration product prototype based on the findings from Aim 1 will be developed. Teacher will test the prototype Movement Integration Product in their classrooms for four weeks.
- Physical Activity [ Time Frame: 5 school days ]Change in self-reported use of movement integration strategies. Teachers will complete a weekly log of movement integration product implementation. To complete the log, each teacher will log onto a password-protected website. Teachers will indicate the number of minutes per day they used the MI product and academic subjects in which the MI product was used. If teachers fail to complete the log they will receive an email reminder.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03394846
|Contact: Robert G Weaver, Phdemail@example.com|
|United States, South Carolina|
|University of South Carolina||Recruiting|
|Columbia, South Carolina, United States, 29205|
|Contact: Robert G Weaver firstname.lastname@example.org|